LOGIN
TEAM
CONTACT US
COLLECTIONS
Bladder
Breast
Leukemia
Liver
Sarcoma
HOME
You need to enable JavaScript to run this app page.
Breast
BCM-0104
Model Details
Patient
PDX Model
Histology
Metastasis
Patient Treatment
Patient Information for Model: BCM-0104
Patient Information
Clinical Timeline
Color Keys:
Positive
Negative
N/A
Clinical Information at Collection
Clinical Biomarkers/Mutations at Collection
Pathology Information at Collection
Model Information for Model: BCM-0104
Model Details - Initial Implantation of Patient Tissue
Biomarkers & Mutations
Model Details - Acceptable Conditions for Passaging
Mutations (Cancer Gene Census List)
Show/Hide Columns
The number of models in this collection with mutations in the listed gene;
may include models that are not publicly available for distribution.
The number of models in this collection with mutations at the listed site;
may include models that are not publicly available for distribution.
Total mutations showing: 36
F
P
1
2
3
N
E
Rows Per Page
10
15
25
50
Download
Gene
Filter by Gene
Chr
Filter by Chr
Start
End
Ref
Alt
cDNA Change
Codon Change
Protein Change
TVAF
Gene Mutation Freq.
Site Mutation Freq.
Most Severe Effect
All Effects
Mutation Impact
Transcript ID
ClinVar Clinical Significance
COSMIC ID
gnomAD Non-Cancer AF
dbSNP ID
Gene Mutation Freq.
Site Mutation Freq.
Transcript ID
ClinVar Clinical Significance
COSMIC ID
dbSNP ID
AFF3
chr2
100007213
100007213
C
T
c.497G>A
aGt/aAt
p.S166N
0.671
12
1
Missense Variant
Missense Variant
MODERATE
ENST00000409579.5
0.000004220760
rs151087811
12
1
ENST00000409579.5
rs151087811
AR
chrX
67545316
67545319
TGCA
T
c.237_239del
ctGCAg/ctg
p.Q80del
0.638
48
9
In-frame Deletion
In-frame Deletion
MODERATE
ENST00000374690.9
COSV65954886
48
9
ENST00000374690.9
COSV65954886
ARHGAP26
chr5
143214082
143214082
G
A
c.2185G>A
Gat/Aat
p.D729N
0.889
3
1
Missense Variant
Missense Variant
MODERATE
ENST00000645722.2
not_provided
0.000005067700
rs587778049
3
1
ENST00000645722.2
not_provided
rs587778049
ARHGEF10
chr8
1928541
1928541
G
A
c.2812G>A
Gtt/Att
p.V938I
0.965
10
2
Missense Variant
Missense Variant
MODERATE
ENST00000349830.8
Likely_benign
COSV50664968
0.005334550000
rs61752020
10
2
ENST00000349830.8
Likely_benign
COSV50664968
rs61752020
ATRX
chrX
77682471
77682471
C
G
c.2785G>C
Gag/Cag
p.E929Q
0.563
59
56
Missense Variant
Missense Variant
MODERATE
ENST00000373344.10
Benign
rs3088074
59
56
ENST00000373344.10
Benign
rs3088074
CIITA
chr16
10909070
10909070
A
G
c.2702A>G
cAg/cGg
p.Q901R
0.992
85
84
Missense Variant
Missense Variant
MODERATE
ENST00000618327.4
Benign
0.983235000000
rs7197779
85
84
ENST00000618327.4
Benign
rs7197779
ERCC2
chr19
45351661
45351661
T
G
c.2251A>C
Aag/Cag
p.K751Q
0.952
48
46
Missense Variant
Missense Variant
MODERATE
ENST00000391945.10
Benign/Likely_benign
COSV67266431
0.322955000000
rs13181
48
46
ENST00000391945.10
Benign/Likely_benign
COSV67266431
rs13181
ETV5
chr3
186081073
186081073
T
C
c.335A>G
tAt/tGt
p.Y112C
0.524
4
1
Missense Variant
Missense Variant
MODERATE
ENST00000306376.10
0.000982127000
rs61760177
4
1
ENST00000306376.10
rs61760177
FOXO3
chr6
108663973
108663973
T
TG
c.1143dup
-/G
p.L382Afs*3
0.168
24
14
Frameshift Mutation
Frameshift Mutation
HIGH
ENST00000406360.2
COSV59629090
rs34133353
24
14
ENST00000406360.2
COSV59629090
rs34133353
HOXC11
chr12
53973625
53973625
C
G
c.384C>G
agC/agG
p.S128R
0.642
3
1
Missense Variant
Missense Variant
MODERATE
ENST00000546378.1
0.000285856000
rs143575026
3
1
ENST00000546378.1
rs143575026
KMT2C
chr7
152252613
152252613
G
T
c.1402C>A
Ccc/Acc
p.P468T
0.973
52
1
Missense Variant
Missense Variant
MODERATE
ENST00000262189.11
not_provided
0.000715005000
rs140919432
52
1
ENST00000262189.11
not_provided
rs140919432
MAML2
chr11
96092210
96092219
TTGCTGCTGC
T
c.1812_1820del
caGCAGCAGCAa/caa
p.Q619_Q621del
0.829
68
59
In-frame Deletion
In-frame Deletion
MODERATE
ENST00000524717.6
COSV73262593
68
59
ENST00000524717.6
COSV73262593
MAP3K1
chr5
56882021
56882024
TCAA
T
c.2845_2847del
tCAAca/tca
p.T949del
0.906
45
32
In-frame Deletion
In-frame Deletion
MODERATE
ENST00000399503.4
COSV68121469
45
32
ENST00000399503.4
COSV68121469
MUC4
chr3
195791241
195791241
T
TGTCTCCTGCGTAACA
c.338_339insTGTTACGCAGGAGAC
aca/acTGTTACGCAGGAGACa
p.T113_A114insVTQET
0.968
83
76
In-frame Insertion
In-frame Insertion
MODERATE
ENST00000463781.8
COSV62126148
rs71180965
83
76
ENST00000463781.8
COSV62126148
rs71180965
MUC4
chr3
195784872
195784968
TCCTGTGGATGCTGAGGAAGTGTCGGTGACAAGAAGAGGGATGGCGTGACCTGTGGATGCTGAGGAAGGGCTGGTGACAGGAAGAGGGGTGGCCTGA
T
c.6612_6707del
ggTCAGGCCACCCCTCTTCCTGTCACCAGCCCTTCCTCAGCATCCACAGGTCACGCCATCCCTCTTCTTGTCACCGACACTTCCTCAGCATCCACAGGa/gga
p.P2214_S2245del
0.45
83
1
In-frame Deletion
In-frame Deletion
MODERATE
ENST00000463781.8
rs1730670340
83
1
ENST00000463781.8
rs1730670340
Total mutations showing: 36
F
P
1
2
3
N
E
Rows Per Page
10
15
25
50
Download
CNV
Histology Information for Model: BCM-0104
Patient
PDX
ER
H&E
HER2
PR
Metastasis Information for Model: BCM-0104
Patient
PDX
Abdomen
Abdominal cavity
Adrenal Gland
Anterosuperior mediastinum
Ascites
Axillary Lymph Node
Bone
Brain
CTC
Chest
Chest wall
Contralateral Breast
Fallopian tubes
Head
Hilar Node
Hip
Kidney
Leg bone
Leptomeninges
Liver
Lung
Lymph Node
Mediastinum
Metastasis Pleura
Neck
None
Other
Ovary
Pancreas
Paratracheal adenopathy
Pericardium
Peritoneal cavity
Peritoneum
Pleura
Pleural cavity
Pleural effusion
Posterior cervical nodes
Pulmonary
Retrocrural Lymph Node
SVC node
Sacral Spine
Skin
Spine
Spleen
Thymus
Patient Treatment Information for Model: BCM-0104
Event Id
Treatment
Treatment Setting
Age at Start
Age at End
Duration
Clinical Response
Pathologic Response
Reason Stopped
10
Paclitaxel
Neoadjuvant
58.26
58.46
73 days
Partial Response
Not Applicable
Other
15
Paclitaxel
Neoadjuvant
58.67
58.7
11 days
Progressive Disease
No Response (NR)
Disease Progression
25
Radiation Therapy (RT)
Recurrent/Metastatic
59.29
59.42
47 days
Not Reported
Not Applicable
Treatment Completed
40
Radiation Therapy (RT)
Recurrent/Metastatic
59.96
59.96
Unknown
Not Reported
Not Applicable
Disease Progression
Timeout
Your session is about to expire. Click 'Stay Connected' to continue the session.
Stay Connected